Very low‐dose versus standard dose radiation therapy for indolent primary cutaneous B‐cell lymphomas: A retrospective study

[1]  R. Weterings,et al.  Geographic Distribution of Otolaryngologists in the United States , 2016, Ear, nose, & throat journal.

[2]  Christine F. Wogan,et al.  Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy , 2016, Leukemia & lymphoma.

[3]  A. Dal Cin,et al.  Primary Cutaneous B-Cell Lymphoma: Role of Surgery , 2011, The Canadian journal of plastic surgery = Journal canadien de chirurgie plastique.

[4]  S. Parker,et al.  Intralesional corticosteroid therapy for primary cutaneous B‐cell lymphoma , 2010, The British journal of dermatology.

[5]  D. Rigel,et al.  Trends in dermatology: geographic density of US dermatologists. , 2010, Archives of dermatology.

[6]  E. Noordijk,et al.  Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas. , 2009, International journal of radiation oncology, biology, physics.

[7]  L. Medeiros,et al.  Primary cutaneous marginal zone B-cell lymphoma. , 2006, American journal of clinical pathology.